Sight Sciences, Inc. (SGHT) Investor Relations Documents

Sight Sciences, Inc. (SGHT) investor relations documents from the company's IR site: 25 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-05Press releaseSight Sciences Reports Second Quarter 2026 Financial Results
2026-08-05Press releaseSight Sciences Announces Aetna Coverage for OMNI and SION Surgical Systems
2026-08-04Press releaseSight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System
2026-07-22Press releaseSight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
2026-05-06Press releaseSight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance
2026-04-29Press releaseSight Sciences to Present at Two Upcoming Investor Conferences
2026-04-22Press releaseSight Sciences Announces the Release of its Sustainability Report
2026-04-21Press releaseSight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026
2026-04-01Press releaseSight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Present
2026-03-30Press releaseSight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th
2025-03-05Press releaseEarnings Release
2024-10-17Press releaseEarnings Release
2024-08-01Press releaseEarnings Release
2024-05-02Press releaseEarnings Release
2024-03-07Press releaseEarnings Release
2023-11-07Press releaseEarnings Release
2023-08-03Press releaseEarnings Release
2023-05-04Press releaseEarnings Release
2023-03-13Press releaseEarnings Release
2022-11-10Press releaseEarnings Release
2022-08-11Press releaseEarnings Release
2022-05-10Press releaseEarnings Release
2022-03-24Press releaseEarnings Release
2021-11-10Press releaseEarnings Release
2021-08-12Press releaseEarnings Release

SGHT overview · SGHT earnings · SGHT financials · SGHT KPIs · SGHT ownership · SGHT peers · SGHT filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.